Skip to main content

Table 1 Baseline patient characteristics

From: Comparison of vildagliptin twice daily vs. sitagliptin once daily using continuous glucose monitoring (CGM): Crossover pilot study (J-VICTORIA study)

Characteristic

Value

Age (years)

55.2 ± 15.5

Gender (M/F)

13/7

Body Mass Index (Kg/m2)

25.1 ± 5.4

Diabetes Duration (years)

4.5 ± 3.7

HbA1c (%)

7.9 ± 0.7

Treatment

 

None (diet/exercise)

12

SU

8

  1. HbA1c = glycosylated hemoglobin; SU = sulfonylurea.